R
R

Richemont

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

European shares firm after ECB stands pat on policy

(There will be no European market report on Friday and Monday on account of Good Friday and Easter. Reuters will resume coverage on Tuesday, April 19.) * ECB confirms plans to end stimulus; gradual rate hikes eyed in Q3 * STOXX 600 rises 0.7% * Volkswagen down on glum outlook * Tech stocks underperform By Anisha Sircar and Sruthi Shankar April 14 (
K
R
E
F
U
G

Mixed earnings cap gains in European shares ahead of ECB decision

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) April 14 (Reuters) - European shares held steady on Thursday after a mixed batch of earnings, while investors waited to hear from the European Central Bank amid risks to economic growth from rising inflation. The pan-European STOXX 600 index
K
R
E
F
U
G

Stocks slip on inflation concerns as oil prices rise further

* Investors brace for tighter monetary policy * Oil hits fresh 7-year high after Turkey pipeline outage * Wall Street can't hold initial gains, Europe pares gains * Value shares trend higher as growth stocks slip By Herbert Lash and Lawrence White NEW YORK/LONDON, Jan 19 (Reuters) - Strong U.S. and European corporate results helped stock markets in
A
E
R
U
G
J
U
U
O
B

Stocks steady, bond yields jump as inflation fears crescendo

* Investors brace for tighter monetary policy * Oil hits fresh 7-year high after Turkey pipeline outage * Rate-sensitive tech stocks lead stock market decline By Lawrence White and Daniel Leussink LONDON/TOKYO, Jan 19 (Reuters) - Strong earnings updates in the United States and Europe helped shares recover on Wednesday from earlier falls driven by
A
E
R
U
G
J
O
B

European stocks fall as Omicron worries rattle investors

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * STOXX 600 gives back a chunk of Wednesdays gains * Apple suppliers hit by report on slowing demand * Vifor Pharma surges on takeover speculation (Updates to close) By Anisha Sircar and Susan Mathew Dec 2 (Reuters) - European shares fell mo
A
H
I
R
V
A
G
E
F
U

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.